Avelumab: Preliminary Phase Ib data

Preliminary data from 6 patients with previously untreated advanced RCC in the open-label, international Phase Ib JAVELIN Renal 100 trial showed that 5 or 10 mg/kg IV avelumab every 2 weeks plus twice...